Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 21909 / DOSAGE - TABLET, ORALLY DISINTEGRATING;ORAL - 30MG
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| fexofenadine hydrochloride(UNII: 2S068B75ZU) (fexofenadine - UNII:E6582LOH6V) | fexofenadine hydrochloride | 6mg in 1 | 180mg | 60mg | 30mg | 30mg |
Inactive Ingredients
| Ingredient Name | Chattem, Inc. | sanofi-aventis U.S. LLC |
|---|---|---|
| ANHYDROUS CITRIC ACID(XF417D3PSL) | ||
| aspartame(Z0H242BBR1) | ||
| butylparaben(3QPI1U3FV8) | ||
| cellulose acetate(3J2P07GVB6) | ||
| cellulose, microcrystalline(OP1R32D61U) | ||
| croscarmellose sodium(M28OL1HH48) | ||
| crospovidone(68401960MK) | ||
| edetate disodium(7FLD91C86K) | ||
| hypromelloses(3NXW29V3WO) | ||
| magnesium stearate(70097M6I30) | ||
| mannitol(3OWL53L36A) | ||
| poloxamer 407(TUF2IVW3M2) | ||
| polyethylene glycols(3WJQ0SDW1A) | ||
| povidone K30(U725QWY32X) | ||
| povidone(FZ989GH94E) | ||
| POVIDONES(FZ989GH94E) | ||
| propylene glycol(6DC9Q167V3) | ||
| propylparaben(Z8IX2SC1OH) | ||
| silicon dioxide(ETJ7Z6XBU4) | ||
| SODIUM BICARBONATE(8MDF5V39QO) | ||
| sodium chloride(451W47IQ8X) | ||
| sodium phosphate, dibasic, heptahydrate(70WT22SF4B) | ||
| sodium phosphate, monobasic, monohydrate(593YOG76RN) | ||
| SODIUM STARCH GLYCOLATE TYPE A POTATO(5856J3G2A2) | ||
| sucrose(C151H8M554) | ||
| titanium dioxide(15FIX9V2JP) | ||
| water(059QF0KO0R) | ||
| xanthan gum(TTV12P4NEE) | ||
| xylitol(VCQ006KQ1E) |
LOOKING FOR A SUPPLIER?
Market Place
